1. Home
  2. MYNZ vs IBG Comparison

MYNZ vs IBG Comparison

Compare MYNZ & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • IBG
  • Stock Information
  • Founded
  • MYNZ 2021
  • IBG 2018
  • Country
  • MYNZ Germany
  • IBG Australia
  • Employees
  • MYNZ N/A
  • IBG N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • IBG Beverages (Production/Distribution)
  • Sector
  • MYNZ Health Care
  • IBG Consumer Staples
  • Exchange
  • MYNZ Nasdaq
  • IBG Nasdaq
  • Market Cap
  • MYNZ 7.9M
  • IBG 7.8M
  • IPO Year
  • MYNZ 2021
  • IBG 2024
  • Fundamental
  • Price
  • MYNZ $1.49
  • IBG $3.43
  • Analyst Decision
  • MYNZ Buy
  • IBG Strong Buy
  • Analyst Count
  • MYNZ 2
  • IBG 1
  • Target Price
  • MYNZ $14.00
  • IBG N/A
  • AVG Volume (30 Days)
  • MYNZ 499.8K
  • IBG 7.2M
  • Earning Date
  • MYNZ 09-26-2025
  • IBG 11-15-2025
  • Dividend Yield
  • MYNZ N/A
  • IBG N/A
  • EPS Growth
  • MYNZ N/A
  • IBG N/A
  • EPS
  • MYNZ N/A
  • IBG N/A
  • Revenue
  • MYNZ $659,935.00
  • IBG $2,931,243.00
  • Revenue This Year
  • MYNZ $26.06
  • IBG N/A
  • Revenue Next Year
  • MYNZ $4.97
  • IBG N/A
  • P/E Ratio
  • MYNZ N/A
  • IBG N/A
  • Revenue Growth
  • MYNZ N/A
  • IBG N/A
  • 52 Week Low
  • MYNZ $1.28
  • IBG $1.48
  • 52 Week High
  • MYNZ $14.39
  • IBG $9.85
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 43.48
  • IBG 58.53
  • Support Level
  • MYNZ $1.28
  • IBG $2.93
  • Resistance Level
  • MYNZ $1.73
  • IBG $4.94
  • Average True Range (ATR)
  • MYNZ 0.14
  • IBG 0.56
  • MACD
  • MYNZ -0.01
  • IBG -0.06
  • Stochastic Oscillator
  • MYNZ 44.67
  • IBG 20.41

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.

Share on Social Networks: